Antiviral agents play a critical role in combating viral infections, which can disrupt the body’s defense and lead to a wide range of diseases, from acute illnesses to chronic conditions. Compiled using the latest data from authoritative sources, Library of Antiviral Compounds includes compounds targeting essential viral proteins. It features inhibitors of viral entry, replication, transcription, translation, and assembly, as well as molecules that interfere with host-virus interactions crucial for viral survival and propagation.

The library encompasses both approved antiviral drugs and investigational compounds with known biological activity against various viral families, including RNA viruses (e.g., coronaviruses, influenza viruses) and DNA viruses (e.g., herpesviruses, papillomaviruses). Each molecule is carefully annotated with its mechanism of action, target specificity, and therapeutic relevance, providing a rich resource for the study of viral biology and therapeutic intervention.

This comprehensive library consists of 842 compounds and supports research in antiviral drug discovery, focusing on diverse viral targets and pathways to develop novel therapeutics. Detailed annotations facilitate the understanding of molecular interactions with viral and host targets, aiding in the identification of biomarkers for viral infection, disease progression, and treatment response.

Related terms: antivirals, HIV, herpes, hepatitis, SARS, coronavirus, influenza